spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  tenapanor 

 HSMN NewsFeed - 29 Dec 2022
FDA Grants Appeal for Ardelyx's XPHOZAH(R) (tenapanor)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 4 Apr 2022
Ardelyx Announces US Launch of IBSRELA(R), a New First-in-Class Treatment for IBS-C in Adults
Biopharmaceuticals Gastroenterology Product Launch
 HSMN NewsFeed - 13 Sep 2018
Ardelyx Submits New Drug Application for U.S. Marketing Authorization of Tenapanor for IBS-C to U.S. Food and Drug Administration
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 19 Mar 2018
Ardelyx and Knight Collaborate to Bring Tenapanor to Patients in Canada
Biopharmaceuticals Gastroenterology Licensing
 HSMN NewsFeed - 12 Feb 2018
Ardelyx Announces Departure of Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Dec 2017
Ardelyx Announces License Agreement with Shanghai Fosun Pharmaceutical Industrial Development Company Limited for Tenapanor in China
Biopharmaceuticals Gastroenterology Licensing
 HSMN NewsFeed - 21 Nov 2017
Ardelyx Announces Updated Development Path for its Cardiorenal Pipeline
Biopharmaceuticals
 HSMN NewsFeed - 12 May 2017
Ardelyx Reports Successful Phase 3 T3MPO-1 Trial of Tenapanor in Patients with IBS-C
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 24 Oct 2016
Ardelyx Strengthens Executive Leadership with the Appointment of Reginald Seeto, MBBS, as Chief Operating Officer
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 15 Jul 2016
Ardelyx to Raise $110 Million in a Private Placement
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Jan 2016
Ardelyx Strengthens Executive Leadership Team with the Appointment of Paul Korner, MD, MBA, as Executive Vice President and Chief Medical Officer
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 3 Jun 2015
Ardelyx to Raise $77.8 Million in a Private Placement and Announces New Product Candidate for the Treatment of Hyperkalemia to Begin Clinical Development in Mid-2015
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Jun 2015
Ardelyx Regains Worldwide Development and Commercialization Rights for Its Late-Stage Development Candidate, Tenapanor, and Related Portfolio of NHE3 Compounds
Biopharmaceuticals Gastroenterology Acquisitions
Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.